Loading...
XSHG600976
Market cap854mUSD
Jan 08, Last price  
40.82CNY
1D
-1.45%
1Q
-12.89%
Jan 2017
27.84%
Name

Jianmin Pharmaceutical Group Co Ltd

Chart & Performance

D1W1MN
XSHG:600976 chart
P/E
12.01
P/S
1.49
EPS
3.40
Div Yield, %
0.00%
Shrs. gr., 5y
-0.04%
Rev. gr., 5y
14.28%
Revenues
4.21b
+15.72%
530,230,282911,088,4401,291,749,9091,036,121,096835,351,7661,533,865,7191,571,985,4791,412,848,8841,539,745,1691,992,391,1181,753,488,3892,281,220,6002,363,653,0712,711,502,8222,161,476,6372,238,937,1232,455,996,2983,278,183,6403,640,800,4774,213,154,572
Net income
521m
+27.78%
28,007,01120,020,96711,487,1548,326,46615,778,43648,857,82771,686,22278,251,42682,450,68995,903,530115,970,44285,500,17064,655,61190,777,56081,217,73591,490,271147,788,378305,258,203408,080,739521,457,677
CFO
268m
+24.33%
4,132,674056,175,2020110,107,98366,693,463150,079,034098,173,81645,358,292103,228,93448,449,871113,840,27135,197,18263,598,25374,449,432125,538,929259,183,455215,865,263268,389,661
Dividend
Apr 26, 20241.2 CNY/sh
Earnings
Apr 08, 2025

Profile

Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells Chinese medicines in China. It offers pediatric drugs under the Jianmin and Longmu brands. The company also provides OTC, medical, and health products, as well as consultation service. Jianmin Pharmaceutical Group Co.,Ltd. is headquartered in Wuhan, China.
URL
http://www.whjm.com/
IPO date
Apr 19, 2004
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
4,213,155
15.72%
3,640,800
11.06%
Cost of revenue
3,549,385
3,239,293
Unusual Expense (Income)
NOPBT
663,769
401,507
NOPBT Margin
15.75%
11.03%
Operating Taxes
47,859
32,439
Tax Rate
7.21%
8.08%
NOPAT
615,910
369,068
Net income
521,458
27.78%
408,081
33.68%
Dividends
(123,341)
Dividend yield
1.63%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
79,445
29,858
Long-term debt
60,589
46,962
Deferred revenue
12,181
Other long-term liabilities
18,610
1
Net debt
(1,509,968)
(783,891)
Cash flow
Cash from operating activities
268,390
215,865
CAPEX
(64,502)
Cash from investing activities
(180,502)
Cash from financing activities
(85,696)
FCF
527,808
331,952
Balance
Cash
999,578
860,711
Long term investments
650,424
Excess cash
1,439,344
678,671
Stockholders' equity
1,595,919
1,389,084
Invested Capital
945,490
1,182,273
ROIC
57.89%
35.69%
ROCE
27.77%
21.57%
EV
Common stock shares outstanding
152,920
152,498
Price
65.25
31.31%
49.69
-37.01%
Market cap
9,978,039
31.68%
7,577,615
-36.75%
EV
8,476,850
6,798,697
EBITDA
722,826
440,328
EV/EBITDA
11.73
15.44
Interest
4,820
4,809
Interest/NOPBT
0.73%
1.20%